These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19758475)

  • 21. Task-based profile of vocal intensity decline in Parkinson's disease.
    Rosen KM; Kent RD; Duffy JR
    Folia Phoniatr Logop; 2005; 57(1):28-37. PubMed ID: 15655339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of the listening in spatialized noise test.
    Cameron S; Dillon H; Newall P
    Ear Hear; 2006 Feb; 27(1):30-42. PubMed ID: 16446563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life with communication changes in Parkinson's disease.
    Miller N; Noble E; Jones D; Burn D
    Age Ageing; 2006 May; 35(3):235-9. PubMed ID: 16540492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Articulatory movements during vowels in speakers with dysarthria and healthy controls.
    Yunusova Y; Weismer G; Westbury JR; Lindstrom MJ
    J Speech Lang Hear Res; 2008 Jun; 51(3):596-611. PubMed ID: 18506038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perception of stop consonants produced by esophageal and tracheoesophageal speakers.
    Gomyo Y; Doyle PC
    J Otolaryngol; 1989 Jun; 18(4):184-8. PubMed ID: 2739001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vocal acoustic characteristics of patients with Parkinson's disease.
    Tanaka Y; Nishio M; Niimi S
    Folia Phoniatr Logop; 2011; 63(5):223-30. PubMed ID: 21212679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of the lax vowel space in dysarthria.
    Tjaden K; Rivera D; Wilding G; Turner GS
    J Speech Lang Hear Res; 2005 Jun; 48(3):554-66. PubMed ID: 16197272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of training on naïve listeners' judgments of the speech intelligibility of children with severe-to-profound hearing loss.
    Ellis LW; Beltyukova SA
    J Speech Lang Hear Res; 2008 Oct; 51(5):1114-23. PubMed ID: 18664708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.
    Anand S; Stepp CE
    J Speech Lang Hear Res; 2015 Aug; 58(4):1134-44. PubMed ID: 26102242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Acoustic Perceptual Relationship of Speech in Parkinson's Disease.
    Chiu YF; Neel A; Loux T
    J Speech Lang Hear Res; 2021 May; 64(5):1560-1570. PubMed ID: 33900806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
    De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
    Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intensive voice treatment on tone-language speakers with Parkinson's disease.
    Whitehill TL; Wong LL
    Clin Linguist Phon; 2007; 21(11-12):919-25. PubMed ID: 17972188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease.
    Dias AE; Barbosa ER; Coracini K; Maia F; Marcolin MA; Fregni F
    Acta Neurol Scand; 2006 Feb; 113(2):92-9. PubMed ID: 16411969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual Analog Scale Ratings and Orthographic Transcription Measures of Sentence Intelligibility in Parkinson's Disease With Variable Listener Exposure.
    Abur D; Enos NM; Stepp CE
    Am J Speech Lang Pathol; 2019 Aug; 28(3):1222-1232. PubMed ID: 31296027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speech rate effects upon intelligibility and acceptability of dysarthric speech.
    Dagenais PA; Brown GR; Moore RE
    Clin Linguist Phon; 2006; 20(2-3):141-8. PubMed ID: 16428230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.